Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus?
Daniele SantiMichela LocasoAntonio R GranataTommaso TrentiLaura RoliChiara PacchioniVincenzo RochiraCesare CaraniManuela SimoniPublished in: PloS one (2018)
The predicted cardiovascular risk is different depending on the algorithm chosen. Despite no predictive risk reduction after six months of treatment, a possible effect of Vardenafil could be hypothesized through its action on inflammation markers reduction and through restoration of normal testosterone levels.